Related Experiment Video

Updated: May 8, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Regulation of mammalian target of rapamycin complex 1 by Bcl-2 and Bcl-XL proteins

Huafei Zou1, Yumei Lai, Xuwen Zhao

  • 1From the Department of Pharmacology and Chemical Biology and.

The Journal of Biological Chemistry
|August 21, 2013
PubMed

Insights

The antiapoptotic proteins Bcl-2 and Bcl-XL influence cell growth regulator mTORC1 signaling. This interaction, mediated by FKBP38, impacts cell metabolism and may contribute to cancer development.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Mammalian target of rapamycin complex 1 (mTORC1) is a central regulator of cell growth, proliferation, and metabolism.
  • mTORC1 activity is modulated by diverse signals including growth factors, nutrients, and cellular stress.
  • Apoptosis regulators, such as Bcl-2 and Bcl-XL, are known for their roles in programmed cell death.

Purpose of the Study:

  • To investigate the functional relationship between Bcl-2/Bcl-XL protein expression and mTORC1 signaling.
  • To elucidate the molecular mechanism underlying the interaction between Bcl-2/Bcl-XL and mTORC1.
  • To determine the potential implications of this cross-talk in cellular processes and disease.

Main Methods:

  • Analysis of mTORC1 signaling activity in cells with altered Bcl-2 and Bcl-XL expression levels.
  • Investigation of the role of FKBP38 as a potential mediator between Bcl-2/Bcl-XL and mTORC1.
  • Biochemical assays to assess protein-protein interactions and signaling pathway modulation.

Main Results:

  • Overexpression of Bcl-XL enhances mTORC1 activity, rendering it less responsive to growth factor and nutrient availability.
  • Reduced expression of Bcl-2 and Bcl-XL leads to inhibition of mTORC1 signaling.
  • Evidence suggests that Bcl-2 and Bcl-XL compete with mTORC1 for binding to the inhibitor FKBP38, thereby regulating mTORC1 activity.

Conclusions:

  • A novel cross-talk exists between Bcl-2/Bcl-XL proteins and mTORC1 signaling pathways.
  • This interaction is mediated by FKBP38, influencing cellular growth and metabolism.
  • The identified cross-talk represents a potential mechanism contributing to cancer development and progression.
Keywords:
Bcl-2Bcl-XLFKBP38MitochondriaS6 KinaseSignalingmTOR Complex (mTORC)mTORC1

More Related Videos

Development and Application of Rapamycin-regulated Tyrosine Phosphatases06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Examining BCL-2 Family Function with Large Unilamellar Vesicles08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...